Five Prime Therapeutics Stock Price (NASDAQ:FPRX)

Add to My Stocks
$35.98 $1.09 (3.12%) FPRX stock closing price Mar 24, 2017 (Closing)
YOUR DAILY UPDATE ON
FPRX
Five Prime Therapeutics
24 MAR 2017
amigobulls logo
FPRX hand_up
FPRX vs S&P 500
Closing Price: Mar 24, 2017
FPRX
$35.98 ( 3.12%)
S&P 500
2344 ( -0.08%)
FPRX
52 Week Price Range
1 Year Return: -6.49%
Q4 Growth*
Poor
Profitable ?
No
net image
2016 Q4 Net Loss
-214.1%
home image
Rating
FPRX AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Five Prime Therapeutics Snapshot Video

11 5 2

FPRX Stock Details

Prev Close* : $34.89
Market Cap:
$1.04B
Day Low: $34.85
52 Week Low: $34.34
Open: $35.48
Volume: 805893
Day High: $36.49
52 Week High: $60.98
Dividend:
N/A

Latest Stock Market News

Latest Articles

Five Prime Therapeutics News - From Partners

FPRX Stockcharts

View FPRX PE ratio, PS ratio stocks charts and compare with peers.
FPRX Chart
Note: Compare Five Prime Therapeutics stock price history with the index and industry peers.

Five Prime Therapeutics Valuation

PS ratio (
price to sales ratio
)
32.17
PB ratio (
price to book ratio
)
2.37

FPRX Industry Peers

Company Price Change (%)
Prometic Life Science (PFSCF)1.650 (0%)
Alder Biopharma (ALDR)21.350.65 (3.14%)
Bristol-myers Squibb (BMY)55.890.12 (0.22%)
Bluebird Bio (BLUE)88.11.15 (1.32%)
Pfizer (PFE)340.29 (0.85%)
Glaxosmithkline (GSK)42.310 (0%)
Eli Lilly (LLY)84.180.24 (0.28%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Five Prime Therapeutics Inc Stock News - Partner Headlines

Value Investing in BioPharma   on Nov 18, 2015

Five Prime Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues30.69M379.8M19.23M13.79M9.98M
Net Income-65.7M249.64M-37.42M-28.87M-27.59M
Total Operating Expense-92.82M56.8M43.2M37.77M
view Five Prime Therapeutics Inc income statement
balance sheet20152014201320122011
Total Assets548.28M155.63M81.79M44.09M58.57M
Total Liabilities115.07M70.42M23.76M23.68M19.22M
Shareholders Equity433.2M85.2M58.02M20.4M39.35M
view Five Prime Therapeutics Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities36.22M46.18M-0.23M5.42M-1.93M
Net Cash From (Used By) Operating Activities289.09M15.26M-25.33M-18.39M23.28M
Increase (Decrease) In Prop Plant And Equipment-2.42M-1.64M-0.8M-0.73M-0.97M
view Five Prime Therapeutics Inc cashflow statement

Five Prime Therapeutics Stock Message Board

Five Prime Therapeutics stock price ended the last trading day at 35.98. Looking at Five Prime Therapeutics market capitalization, which currently stands at 1.01B, we can say that FPRX stock is a Small cap stock. Five Prime Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy FPRX stock than sell it, then Five Prime Therapeutics stock price goes up. Conversely, if more investors wanted to sell FPRX stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Five Prime Therapeutics stock quote data shows the number of shares traded. For Ex: 805893 Five Prime Therapeutics shares were traded as of last trading day, as seen from Five Prime Therapeutics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Five Prime Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.